EA201291460A1 - Олигобензамидные соединения и их применение - Google Patents
Олигобензамидные соединения и их применениеInfo
- Publication number
- EA201291460A1 EA201291460A1 EA201291460A EA201291460A EA201291460A1 EA 201291460 A1 EA201291460 A1 EA 201291460A1 EA 201291460 A EA201291460 A EA 201291460A EA 201291460 A EA201291460 A EA 201291460A EA 201291460 A1 EA201291460 A1 EA 201291460A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- oligobenzamide
- application
- tris
- bis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 230000005540 biological transmission Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34955510P | 2010-05-28 | 2010-05-28 | |
| PCT/US2011/038395 WO2011150360A1 (en) | 2010-05-28 | 2011-05-27 | Oligo-benzamide compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201291460A1 true EA201291460A1 (ru) | 2013-11-29 |
Family
ID=45004429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201291460A EA201291460A1 (ru) | 2010-05-28 | 2011-05-27 | Олигобензамидные соединения и их применение |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20130231385A1 (enExample) |
| EP (1) | EP2575453B1 (enExample) |
| JP (3) | JP2013528174A (enExample) |
| KR (1) | KR20130115108A (enExample) |
| CN (1) | CN102958364A (enExample) |
| AU (1) | AU2011258009B2 (enExample) |
| BR (1) | BR112012030298A2 (enExample) |
| CA (1) | CA2800811C (enExample) |
| CL (1) | CL2012003322A1 (enExample) |
| CO (1) | CO6640301A2 (enExample) |
| EA (1) | EA201291460A1 (enExample) |
| MX (1) | MX2012013855A (enExample) |
| SG (1) | SG186076A1 (enExample) |
| WO (1) | WO2011150360A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012013855A (es) | 2010-05-28 | 2013-04-08 | Univ Texas | Compuestos de oligobenzamida y su uso. |
| US9132281B2 (en) * | 2011-06-21 | 2015-09-15 | The Johns Hopkins University | Focused radiation for augmenting immune-based therapies against neoplasms |
| WO2013078288A1 (en) * | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Oligo-benzamide compounds for use in treating cancers |
| WO2013078277A1 (en) | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Oligo-benzamide compounds and their use in treating cancers |
| CN103665043B (zh) | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药及其在医药上的应用 |
| CN114272242A (zh) * | 2015-05-18 | 2022-04-05 | 康堤医疗有限公司 | 用于治疗性激素依赖性疾病的双重nk-1/nk-3受体拮抗剂 |
| CN108271347B (zh) | 2015-09-15 | 2021-04-20 | 萨维奇医疗股份有限公司 | 用于在组织腔中锚定护套的装置和方法 |
| USD874674S1 (en) * | 2016-10-17 | 2020-02-04 | Brandcore Limited | Vibrator |
| JP7558167B2 (ja) * | 2018-12-03 | 2024-09-30 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | オリゴベンズアミド類似体およびがん処置におけるそれらの使用 |
| WO2023154856A1 (en) * | 2022-02-11 | 2023-08-17 | Board Of Regents, The University Of Texas System | Oligo-benzamide analogs and their use in cancer treatment |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1903899A (en) | 1933-04-18 | Cabboxylic acid abylides oe the benzene sebies and process oe making | ||
| US3951914A (en) | 1974-07-30 | 1976-04-20 | E. I. Du Pont De Nemours And Company | Process for preparing poly(1,4-benzamide) in cyclic sulfone media |
| US5212203A (en) | 1986-01-21 | 1993-05-18 | Centre International De Recherches Dermatogologiques (C.I.R.D.) | Aromatic benzamido compounds; their preparation and their use in human or veterinary medicine or in cosmetic preparations |
| US5734081A (en) | 1994-08-05 | 1998-03-31 | Warner-Lambert Company | Arylthio compounds |
| ATE311366T1 (de) | 2000-02-29 | 2005-12-15 | Millennium Pharm Inc | Benzamide und ähnliche inhibitoren vom faktor xa |
| US7355081B2 (en) * | 2002-04-17 | 2008-04-08 | The University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
| US7217720B2 (en) * | 2003-09-10 | 2007-05-15 | Merck & Co., Inc. | 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| EP1718323B1 (en) | 2004-02-20 | 2011-12-07 | The Trustees of The University of Pennsylvania | Binding peptidomimetics and uses of the same |
| US20070248535A1 (en) | 2005-02-07 | 2007-10-25 | The Trustees Of Columbia University In The City Of New York | Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity |
| US20070129353A1 (en) | 2005-11-08 | 2007-06-07 | Michael Kahn | Alpha-helix mimetics and method relating to the treatment of cancer stem cells |
| US8236983B2 (en) | 2008-03-13 | 2012-08-07 | Board Of Regents, The University Of Texas System | Composition and method for the treatment of diseases affected by apoptosis |
| US7816324B2 (en) | 2007-03-13 | 2010-10-19 | Board Of Regents, The University Of Texas System | Composition and method for the treatment of diseases affected by a peptide receptor |
| UY31432A1 (es) * | 2007-10-26 | 2009-05-29 | Compuestos de diarilhidantoina | |
| CN104474529A (zh) | 2008-02-08 | 2015-04-01 | 爱勒让治疗公司 | 治疗性的拟肽大环化合物 |
| MX2010009162A (es) * | 2008-02-22 | 2010-12-21 | Radius Health Inc | Moduladores selectivos del receptor de androgeno. |
| US8188098B2 (en) | 2008-05-19 | 2012-05-29 | Hoffmann-La Roche Inc. | GPR119 receptor agonists |
| CN101643451B (zh) * | 2008-08-07 | 2013-03-06 | 浙江海正药业股份有限公司 | 过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法 |
| CN102245632B (zh) | 2008-10-17 | 2018-10-12 | 达娜-法勃肿瘤研究所公司 | Muc-1胞质结构域肽作为癌症的抑制剂 |
| CA2749947A1 (en) | 2009-01-30 | 2010-08-05 | Bayer Healthcare Llc | Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition |
| MX2012004624A (es) | 2009-10-23 | 2012-08-23 | Panacela Labs Inc | Metodos para tratar canceres positivos para el receptor de androgenos. |
| MX2012013855A (es) * | 2010-05-28 | 2013-04-08 | Univ Texas | Compuestos de oligobenzamida y su uso. |
| WO2013078277A1 (en) | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Oligo-benzamide compounds and their use in treating cancers |
| WO2013078288A1 (en) * | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Oligo-benzamide compounds for use in treating cancers |
-
2011
- 2011-05-27 MX MX2012013855A patent/MX2012013855A/es not_active Application Discontinuation
- 2011-05-27 AU AU2011258009A patent/AU2011258009B2/en active Active
- 2011-05-27 SG SG2012087235A patent/SG186076A1/en unknown
- 2011-05-27 EA EA201291460A patent/EA201291460A1/ru unknown
- 2011-05-27 BR BR112012030298A patent/BR112012030298A2/pt not_active IP Right Cessation
- 2011-05-27 WO PCT/US2011/038395 patent/WO2011150360A1/en not_active Ceased
- 2011-05-27 CA CA2800811A patent/CA2800811C/en active Active
- 2011-05-27 KR KR1020127033981A patent/KR20130115108A/ko not_active Withdrawn
- 2011-05-27 EP EP11787517.9A patent/EP2575453B1/en active Active
- 2011-05-27 US US13/700,500 patent/US20130231385A1/en not_active Abandoned
- 2011-05-27 CN CN2011800323958A patent/CN102958364A/zh active Pending
- 2011-05-27 JP JP2013512048A patent/JP2013528174A/ja active Pending
-
2012
- 2012-11-27 CL CL2012003322A patent/CL2012003322A1/es unknown
- 2012-12-04 CO CO12219956A patent/CO6640301A2/es not_active Application Discontinuation
-
2015
- 2015-11-04 US US14/932,480 patent/US9856206B2/en active Active
-
2016
- 2016-06-21 JP JP2016122278A patent/JP6385986B2/ja active Active
-
2018
- 2018-01-02 US US15/860,095 patent/US10618869B2/en active Active
- 2018-05-22 JP JP2018097720A patent/JP2018131459A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20160130217A1 (en) | 2016-05-12 |
| SG186076A1 (en) | 2013-01-30 |
| CA2800811A1 (en) | 2011-12-01 |
| US20180230087A1 (en) | 2018-08-16 |
| AU2011258009B2 (en) | 2016-04-21 |
| BR112012030298A2 (pt) | 2015-09-29 |
| EP2575453A1 (en) | 2013-04-10 |
| US10618869B2 (en) | 2020-04-14 |
| CN102958364A (zh) | 2013-03-06 |
| WO2011150360A1 (en) | 2011-12-01 |
| EP2575453B1 (en) | 2018-08-01 |
| JP2013528174A (ja) | 2013-07-08 |
| CL2012003322A1 (es) | 2014-03-28 |
| US9856206B2 (en) | 2018-01-02 |
| US20130231385A1 (en) | 2013-09-05 |
| CA2800811C (en) | 2019-02-26 |
| KR20130115108A (ko) | 2013-10-21 |
| JP6385986B2 (ja) | 2018-09-05 |
| CO6640301A2 (es) | 2013-03-22 |
| EP2575453A4 (en) | 2015-12-23 |
| JP2017019769A (ja) | 2017-01-26 |
| AU2011258009A1 (en) | 2013-01-10 |
| MX2012013855A (es) | 2013-04-08 |
| JP2018131459A (ja) | 2018-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201291460A1 (ru) | Олигобензамидные соединения и их применение | |
| JOP20180103A1 (ar) | مركب صيدلاني | |
| EA201270257A1 (ru) | Производные n1-сульфонил-5-фторпиримидинона | |
| EA201170396A1 (ru) | 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции | |
| UA108101C2 (xx) | Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів | |
| EA201300146A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ | |
| EA201490037A1 (ru) | Антагонисты trpv4 | |
| NZ743274A (en) | Substituted tricyclic compounds as fgfr inhibitors | |
| EA201492002A1 (ru) | Противовирусные соединения | |
| EA201890333A1 (ru) | Противовирусные соединения | |
| EA201270254A1 (ru) | Производные 5-фторпиримидинона | |
| EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201491412A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201490423A1 (ru) | СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА | |
| EA201401351A1 (ru) | Производные бензимидазол-пролина | |
| EA201790781A3 (ru) | Противовирусные соединения | |
| EA201270720A1 (ru) | Модуляторы рецептора андрогенов и их применение | |
| EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
| UA113062C2 (xx) | Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону | |
| EA201270741A1 (ru) | Пероральные композиции и липофильные соли метилналтрексона | |
| EA201401193A1 (ru) | Триарильные соединения и композиции, их содержащие | |
| EA201290772A1 (ru) | Новые формы ивабрадина гидрохлорида | |
| EA201590887A1 (ru) | Композиция | |
| EA201290642A1 (ru) | Соединения и способы | |
| EA201270253A1 (ru) | Производные n1-ацил-5-фторпиримидинона |